You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic%20idiopathic%20myelofibrosis%20(cIMF)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Cleveland (ascorbic acid, arsenic trioxide, dexamethasone)

Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • ascorbic acid
  • +3 more
  • Cleveland, Ohio
  • +1 more
Jul 23, 2020

Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
Mar 2, 2021

68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy

Recruiting
  • Primary Myelofibrosis
  • 68Ga FAPI PET/CT
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Assess the Safety of Fedratinib in Korean Myelofibrosis

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Myelofibrosis Trial (Momelotinib)

Available
  • Myelofibrosis
  • (no location specified)
Oct 12, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +4 more
  • Eltrombopag Olamine
  • Houston, Texas
    M D Anderson Cancer Center
Jan 4, 2022

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Worcester, Massachusetts
  • +16 more
Oct 31, 2022

Immune Thrombocytopenia Trial (Herombopag)

Not yet recruiting
  • Immune Thrombocytopenia
  • (no location specified)
Jan 13, 2023

Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

Recruiting
  • Myelofibrosis
  • +2 more
  • Charlottesville, Virginia
    Danyelle Coley
Jan 18, 2023

Myelofibrosis Trial in Italy (A: Fludarabine + Busulphan, B: Fludarabine + Thiotepa)

Completed
  • Myelofibrosis
  • A: Fludarabine + Busulphan
  • B: Fludarabine + Thiotepa
  • Alessandria, Italy
  • +20 more
Aug 19, 2021

Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 26, 2022

Adenosine Deaminase and Immunoglobulin E in Chronic Spontaneous

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Adenosine deaminase serum level
  • IgE antibodies serum level
  • (no location specified)
Aug 7, 2023

Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Long-term Follow-up
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Birmingham, Alabama
  • +151 more
Aug 22, 2022

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

Completed
  • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 27, 2022

Ruxolitinib in Patients With Myelofibrosis

Not yet recruiting
  • Myelofibrosis
  • (no location specified)
Feb 28, 2023

Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 Tablets
  • TQB3617 Capsules
  • Guangzhou, Guangdong, China
  • +19 more
Nov 7, 2023

Myelofibrosis Trial in Worldwide (GB2064)

Recruiting
  • Myelofibrosis
  • Houston, Texas
  • +11 more
Nov 23, 2022

Myelofibrosis Trial in France (Clonal architecture determination)

Not yet recruiting
  • Myelofibrosis
  • Clonal architecture determination
  • Angers, France
  • +6 more
Jan 24, 2023

Idiopathic Pulmonary Fibrosis Trial in Hialeah Gardens (20mM sodium pyruvate nasal spray, Saline Placebo control nasal spray)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • 20mM sodium pyruvate nasal spray
  • Saline Placebo control nasal spray
  • Hialeah Gardens, Florida
    Family First Medical Research Center
Sep 16, 2023

Myelofibrosis Trial in United States (Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Boston, Massachusetts
  • +4 more
Oct 21, 2022

Accelerated/Blast-phase Myeloproliferative Tumor, Chronic-phase Myelofibrosis, IDH2 Mutation Trial in Canada, United States

Recruiting
  • Accelerated/Blast-phase Myeloproliferative Neoplasm
  • +2 more
  • Scottsdale, Arizona
  • +10 more
May 9, 2022

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Feb 10, 2022

Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis Trial in Worldwide (KRT-232, TL-895)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +36 more
May 5, 2022